Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Cabozantinib shows intriguing activity in heavily pretreated urothelial carcinoma: Objective responsive rate of 19% observed in cohort of patients with metastatic UC
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Source:Urology Times. September, 2020, Vol. 48 Issue 9, p22, 2 p.
No Comments.